Using novel antibodies of high avidity to-and specificity for-the constitutive desmosomal plaque protein, plakophilin-2 (Pkp2), in a systematic study of the molecular composition of junctions connecting the cells of soft tissue tumors, we have discovered with immunocytochemical, biochemical and electron microscopical methods, a novel type of adherens junctions in all 32 cardiac myxomata examined. These junctions contain cadherin-11 as their major transmembrane glycoprotein, which we could repeatedly show in colocalization with N-cadherin, anchored in a cytoplasmic plaque formed by a-and b-catenin, together with the further armadillo-type proteins plakoglobin, p120, p0071 and ARVCF. Surprisingly, all adherens junctions of these tumors contained, in addition, another major armadillo protein Pkp2, hitherto known as an obligatory and characteristic constituent of desmosomes in epithelium-derived tumors. We have not detected Pkp2 in a series of noncardiac myxomata studied in parallel. Therefore, we conclude that this acquisition of Pkp2, which we have recently also observed in some mesenchymally derived cells growing in culture, can also occur in tumorigenic transformations in situ. We propose to examine the marker value of Pkp2 in clinical diagnoses of cardiac myxomata and to develop Pkp2-targeted therapeutic reagents.
The identification of the specific types of transformed cells and of the kind and level of their differentiation is an essential part of tumor diagnosis, not only with respect to the histogenic origin but also as a basis for prognoses and therapeutic decisions. Therefore, molecular markers for cell typing and differentiation have become almost obligatory criteria in pathological diagnoses, in particular of epithelium-derived tumors, for which reliable immunohistochemical marker antibodies are used worldwide [1] [2] [3] [4] (for a review see Chu and Weiss 5 ). However, in the field of mesenchymally derived tumors, the armamentarium of diagnostic markers is still relatively poor and problems of correct identification of certain soft tissue tumors are obvious. 6, 7 Therefore, we have recently begun to systematically determine the molecular composition of potential marker molecules of mesenchymal cell types and the diverse nonepithelial tumors derived therefrom. [6] [7] [8] [9] Surprisingly, already in our initial series of experiments, we have recognized unexpected changes in the molecular ensembles of cell-cell junctions of the adherens category. An especially eye-catching finding has been the phenomenon that a series of mesenchymally derived cells growing in culture, including human tumor cell lines, contain adherens junctions of a drastically altered composition. They are based on clusters of N-cadherin or cadherin-11 anchored in a subplasmalemmal plaque, which contains a-and b-catenin plus several further proteins of the armadillo family such as plakoglobin and proteins p120, p0071 and ARVCF, and in addition also contains another major armadillo-type protein, plakophilin-2 (Pkp2). 10, 11 This rapid acquisition of Pkp2 is perplexing, as plakophilins hitherto have only been known as obligatory molecules specific for desmosomes of epithelial and myocardiac cells as well as of epithelium-derived tumors, including all carcinomas.
We have also noted occasional groups of cells in sections of some tumors of mesenchymal origin, which in immunohistochemistry show adherens junctions positive for Pkp2, indicating that this change in molecular composition of the adherens junctions may also take place during tumor formation in situ. Consequently, we have examined the molecular composition of adherens junctions connecting the cells of various soft tissue tumors. Here, we present as a first result our finding that all adherens junctions connecting cardiac myxoma cells show exactly such a general acquisition of Pkp2.
Materials and methods

Antibodies
To generate highly sensitive antibodies specific for Pkp2 that could also be used on aldehyde-fixed and paraffin-embedded tissues, we have used peptides derived from promising, epitope-containing regions of the human Pkp2 amino-acid (aa) sequence (aa positions 820-837, representing the carboxyterminal aa sequence KTDFVNSRTAKAYHSLKD, and aa positions 611-625; ie, VKEQYQDVPM-PEEKS, representing a segment at the border between armadillo repeats 5 and 6), and conjugated them to keyhole limpet hemocyanin for the immunization of guinea pigs (for details of the molecule and of immunization protocols see Mertens et al 12 ). The polyclonal antibodies selected, termed PP2-hCT (for the carboxy-terminal sequence) and PP2-hM (for the armadillo repeat 5/6 border domain), were of excellent stability and accessibility in biochemical and immunological experiments.
Murine monoclonal antibodies (mAbs) to Pkp2 were generated by immunization of BalbC mice, using peptides derived from aa position 527-872 of the human protein (for method see Holmdahl et al 13 ) . The supernatants of the resulting monoclonal hybridoma cell cultures were screened by immunofluorescence microscopy using methanol/ acetone-fixed epithelial cell cultures (for protocol see Supplementary Information) and tested by immunoblotting of total cellular proteins separated by SDS-PAGE. In addition, we specifically screened for immunostaining reactivity on formaldehydefixed cultured cells and tissue blocks (see below). From a total of ca. 2000 different hybridomas, 3 mAbs (Pkp2-402, Pkp2-407 and Pkp2-518) were prepared in sufficient amounts and characterized in detail. All antibodies routinely used are listed in Supplementary Table 1. 11,14
Tissues
A total of 32 frozen and formaldehyde-fixed and paraffin-embedded samples of human tissues, including a large series of different myxoma types (see Supplementary Information), have been examined. Special diagnostic care was taken to ensure that no malignant heart tumors were included in the study. 15 Samples of heart tissues obtained from various mammalian, avian, amphibian and fish species (cf. Barth et al 10 and Pieperhoff and Franke 16 ) were examined in parallel.
Gel Electrophoresis and Immunoreactions of Proteins
For preparations of control cell lysates, monolayer cell cultures were briefly rinsed twice with phosphate-buffered saline, suspended in sample buffer (250 mM Tris-HCl, 10% SDS, 20% glycerol, 100 mM dithiotreitol; pH 6.8) containing benzonase (1:1000; Merck, Darmstadt, Germany) and scraped off the dishes using a rubber policeman. Small pieces of frozen myxoma and control tissues were also homogenized in sample buffer containing benzonase. After vigorous vortex homogenization, lysates were heated for 5 min at 951C, briefly centrifuged and subjected to SDS-PAGE, followed by blot transfer to PVDF membranes (Millipore, Bedford, MA, USA), and reacted with horseradish peroxidase-conjugated secondary antibodies, applied in combination with a chemiluminescence system (ECL, AmershamBuchler, Braunschweig, Germany).
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Results
Generation of Highly Sensitive Pkp2 Antibodies
To detect Pkp2 deep in adherens junction plaques, notably epitopes masked by obscuring complexes (for nuclei see Mertens et al 12 ) , we have generated improved antibodies for immunohistochemistry. We have recently reported that Pkp2 is not only a permanent constituent of true desmosomes of epithelial, myocardiac or meningeal tissues and of tumors derived therefrom and of the composite junctions of cardiomyocytes 12, 17, 18 but can also be found in diverse lines of mesenchymally derived cell cultures. 11 Therefore, we have decided to examine the possible presence of this plakophilin in adherens junctions of mesenchymal tumors.
The Adherens Junctions Connecting Cardiac Myxoma Cells
Cardiac myxomata are considered as benign tumors generally characterized by 'stellate' cells with variously long cell processes embedded in a jellylike mucoid extracellular matrix. 19 They present a predominantly mesenchymal marker protein profile with abundant bundles of intermediate-sized filaments (IFs) of the vimentin type. Only in a minor proportion of cells in some of these tumors have we noted small groups of cells that are also positive for the IF protein desmin, whereas IFs containing any keratins, glia filament or neurofilament proteins have not been seen. Nonmuscle-type actin microfilaments are prevalent, but in a minor proportion of myxoma cells we have also detected a-smooth muscle-type actin filaments but no sarcomeric a-actins. All our general immunocytochemical observations in the 32 myxomata studied are grosso modo in agreement with most previous reports, indicating a derivation from cardiac mesenchymal cells [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] (for occasional claims of special cardiac myxoma tumor cells showing keratin reactions, mostly in glandular elements, see references 24, 29, 30) .
Most of the myxoma cells formed numerous cell processes and were interconnected into a loose irregular meshwork by punctum adhaerens-type junctions. Consequently, myxoma cells can occur in relatively close apposition, as shown in Figure 2 , or distant from each other, connected only by rather thin, variously long, tentacle-like filopodial cytoplasmic processes. 24, 25 As the very short processes of perinuclear cytoplasm are adequately resolved only by electron microscopy, we show ( Figure 2) an example of such an interaction through short processes and their adherens junctions, characterized by a thin (ca. 15 nm) dense plaque (eg insert in Figure 2b ), that is, myxoma structures that have repeatedly been described in literature as 'desmosome-like'. 8, 28, [31] [32] [33] [34] 
Biochemical Analyses of Adhering Junction Proteins
Our systematic analyses of cryo-dissected tissue samples of various snap-frozen myxomata by SDS-PAGE and immunoblotting revealed consistent but surprising results (Figure 3) . The predominant transmembrane adherens junction glycoprotein identified was cadherin-11. Only in limited regions of some of the tumors was this glycoprotein accompanied by N-cadherin. VE-cadherin, on the other hand, was clearly seen in the zonulae adhaerentes of the endothelial structures of adjacent vascular elements but was totally absent from the myxoma cells proper (see also below). Moreover, we found all major adherens junctional plaque proteins such as a-and b-catenin, plakoglobin, protein p120 (Figure 3) , as well as proteins p0071 and ARVCF (not shown).
Unexpectedly, however, we identified in all cardiac myxomata examined the plaque protein Pkp2 (Figure 3 presents examples from six different tumors analyzed in parallel in the same SDS-PAGE), often together with varying proportions of an immunoblot-positive polypeptide of ca. 70 kDa, obviously a distinct proteolytic breakdown product. In a few tumor samples, we have also noted the additional presence of minor amounts of Pkp3 (not shown), but we have never detected Pkp1. Tests for the most predominant protein in desmosomal plaques, desmoplakin, were negative in all myxoma cells of all cases (not shown).
Immunolocalization Studies
The mostly rather small adherens junctions, which connect the cardiac myxoma cells in their nucleuscontaining central cell bodies, as well as in their slender processes, are recognized by the colocalization of Pkp2 with typical adherens junction markers such as a-and b-catenin, plakoglobin and proteins p120, p0071 or ARVCF, as demonstrated by their yellow to orange merge color (eg, see Figures 4a  and b) . This is in distinct contrast to the absence of Pkp2 from the adherens junctions connecting the vascular endothelial cells (note the green immunostaining for b-catenin in Figure 4a ). In the myxoma cell processes, the adherens junctions are often clustered, resulting in continuously yellow immunostaining (Figure 4b ) or in closely spaced Pkp2-reactive punctate or 'beaded' arrays (Figures 4b-e) . 
Plakophilin-2 in cardiac myxomata
Colocalization of Pkp2 was also obtained with both cadherins mentioned. Cadherin-11 generally colocalized with Pkp2 in serial arrays of yellow dots or in beaded chains of adherens junction structures (eg Figures 5b and c) in the same way as it reacted with b-catenin and other plaque proteins (Supplementary Figures 1a-e) . Similar observations were made with N-cadherin, which appeared only in adherens junctions of certain limited regions in some of the tumors (eg Figure 5a) . Again, all these adherens junction reactions fully contrasted with those of the endothelium of the adjacent vessels (see the red b-catenin reaction in both Figures 5a and b) . In control experiments, VE-cadherin antibodies reacted only with the endothelial junctions, which otherwise contained all the plaque proteins mentioned above, with the exception of Pkp2 (not shown). As a positive colocalization control for junctional plaque immunostaining in the zonulae adhaerentes of vascular endothelium, an a-catenin example is shown in Supplementary Figure 1f .
Much to our surprise we have not detected a Pkp2-positive adherens junction in any of the six noncardiac myxomata examined in parallel (Supplementary Table 2 ).
Discussion
The molecular analysis of the cell-cell junctions in cardiac myxomata has led to the unexpected identification of a novel adherens junction type, the Pkp2-containing one, hitherto only known as coniunctio adhaerens of certain cell cultures 10, 11 (for review see Franke et al 35 ) . Obviously, this adherens junction type represents a cell-cell connecting structure of its own kind, which is characteristic for certain tumors, as shown here for cardiac myxomata. So far, this type of junction has only sporadically been noted in some isolated cells or cell groups in a rhabdomyosarcoma. 11 The mostly rather small, roundish-to-oval adherens junctions identified as the major myxoma cell-cell contacts represent typical mesenchymal structures, albeit with a special molecular composition. In these junctions, we have detected cadherin-11 as the only ubiquitous transmembrane glycoprotein, whereas additional N-cadherin was seen only in restricted regions of a few tumors, which we also take as an indication of the existence of two myxoma cell subtypes distinguished by their adherens junction composition, one with cadherin-11 only and the other containing both cadherin-11 and N-cadherin (for related observations, see Franke et al, 35 Franke, 36 Strumane et al, 37 Butany et al, 38 Reynen, 39 Pucci et al 40 and Burke et al 41 ) . At present, however, we cannot rigorously exclude the alternative explanation that all myxoma adherens junctions may also contain some N-cadherin, which tends to be rapidly degraded by some of the proteolytic enzymes known to occur in tissue preparations from these tumors. 42 The molecular pattern of the adherens junction plaques of the cardiac myxomata is remarkably complex and specific. While most components identified, including a-and b-catenin, together with further armadillo proteins such as plakoglobin and proteins p120, p0071 and ARVCF, have also been found in other nonepithelial cells, 11, [35] [36] [37] it has been a surprise to find that the adherens junction plaques of all 32 myxomata examined contain an additional major armadillo protein, Pkp2, which so far has been considered to be a protein exclusive to desmosomes and to the composite junctions of cardiomyocytes. 12, 17, 35, 43, 44 As shown by Goossens et al, 45 the cardiomyocyte-specific plaque integration of Pkp2 is based on its binding to myocardial a-T-catenin, 45 a protein, however, that does not seem to be present in cardiac myxoma cells. Obviously, the specific molecular binding partners of Pkp2 and the mechanisms and functions of its acquisition to myxoma adherens junctions will have to be determined in future experiments. The stable integration of Pkp2 in the adherens junctions of cardiac myxomata is functionally remarkable, as this protein is known as the only member of the plakophilin subfamily that occurs in all proliferatively active epithelial cells and is also an essential architectonic and cytoskeletal filamentanchoring molecule in the desmosomes and composite junctions of myocardial cells. In the latter it is necessary for heart formation and for the onset and coordination of rhythmic heart beat, 18, [44] [45] [46] [47] [48] be it directly or indirectly (for further involvements of sodium channels or gap junctions, see also recent knockdown experiments). [49] [50] [51] [52] Most impressive in the discussions about possible functional roles of Pkp2 are certainly the recent reports that cardiac Pkp2 is by far the most sensitive protein, which in mutated forms can contribute to arrhythmogenic ventricular cardiomyopathies (ARVCs). [46] [47] [48] [49] [50] [51] [52] [53] Moreover, in Pkp2 gene knockdown experiments, it has also been shown that its stabilizing effect on cell-cell adhesion in rat cardiomyocyte cultures is so important that a reduction in Pkp2 can result in a complete separation of the two junctional membranes. [49] [50] [51] [52] Thus, in myxoma tumors growing in a very viscous, mucoid-gelatinous matrix, the acquisition of Pkp2 to the adherens junctions may have an important stabilizing effect and strengthen cell-cell adhesions, in particular those connecting the long and thin cell processes.
Finally, our findings strongly support the hypothesis that cardiac myxoma cells originate from mesenchymal cells of the heart, as their similarity to the cardiac interstitial cells is remarkable. 10 The molecular marker pattern of cardiac myxomata is indeed very similar to that reported for, for example, valvular interstitial cells in culture, including the extensive and relatively rapid acquisition of Pkp2. Both cardiac interstitial and myxoma cells are also known for a certain spatial or developmental relationship to vascular endothelial cells, and synthesis and secretion of specific endothelial and angiogenic molecules have recently also been ascribed to vascular elements in myxomata. [54] [55] [56] By contrast, certain neural, neuroendocrine or glandular molecules seen in some elements of these tumors may be differentiation products of some cells 'entrapped' during development (for special discussions see, eg, Johansson, 24 Kodama et al, 34 Pucci et al, 40 Krikler et al, 57 Terracciano et al, 58 and Suvarna and Royds 59 ). A rather unexpected finding in our study has been the observation of Pkp2 in all adherens junctions of all 32 cardiac myxomata, whereas we have not detected this junction protein in any of the six noncardiac myxomata, including angiomyxomata of the vagina and the vulva, as well as in skeletal muscle tumors (Supplementary Table 2 ). Differences of molecular markers and possible cell type-specific histological heterogeneities will be the subject of a future report comparing cardiac with various types of noncardiac myxomata, including cutaneous myxomata and also some of the rare myxoma cases showing malignant behavior, that is, recurrence and metastasis (for general discussions of these problems, see Amano et al, 20 Basso et al, 25 Curschellas et al, 29 Keeling et al, 60 Silverman, 61 Weiss and Goldblum 62 ). Although the myxoid nature, with formation of abundant extracellular myxoid matrix, is common to both cardiac and noncardiac myxomata, there seem to be major differences between these tumors, not only with respect to the molecular composition of adherens junctions but also in some general morphological aspects. While cells of cardiac myxomata are often arranged in typical cords, in other myxomatous tumor forms such as intramuscular myxoma and aggressive angiomyxoma, the spindleshaped or stellate tumor cells are loosely distributed and widely separated from each other by myxoid stroma, sometimes seemingly even without any cell-cell contacts (for review see Weiss and Goldblum 62 ). Therefore, we have decided to start a much broader immunocytochemical comparison between cardiac and noncardiac myxoma tumors, including cases from both sexes and diverse organs.
It has also not escaped our attention that the general occurrence of cadherin-11 and Pkp2 in myxoma adherens junctions may lead to new possible therapeutic concepts of molecular interference with these molecules and thus with cell-cell adhesion and tumor growth. Although surgical excision is-and probably will remain-the standard therapy for the majority of myxoma cases, there are also situations in which the value and availability of pharmacological alternatives should not be underrated (see also Burke et al, 41 Gaumann et al, 56 Keeling et al, 60 Silverman 61 ). Certainly, recent strategies and preclinical tests with reagents interfering with N-cadherin-mediated cell-cell interactions 63 and the aforementioned results using the siRNA approach should now also encourage projects interfering with other adherens junction molecules.
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